{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:58:12Z","timestamp":1794434292657,"version":"4.9.1"},"publisher-location":"Totowa, NJ","reference-count":35,"publisher":"Humana Press","isbn-type":[{"value":"9781627030700","type":"print"},{"value":"9781627030717","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-62703-071-7_10","type":"book-chapter","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T14:48:03Z","timestamp":1354286883000},"page":"183-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Reinterpretation of the Pathogenesis and Cure of Cancer According to the Psychoneuroimmunological Discoveries"],"prefix":"10.1007","author":[{"given":"Paolo","family":"Lissoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"10_CR1","first-page":"79","volume":"10","author":"DR Rubinow","year":"1990","unstructured":"Rubinow DR (1990) Brain, behaviour and immunity: an interactive system. J Natl Cancer Inst Monogr 10:79\u201382","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.1994.tb39641.x","volume":"741","author":"BD Jankovic","year":"1994","unstructured":"Jankovic BD (1994) Neuroimmunomodulation. From phenomenology to molecular evidence. Ann N Y Acad Sci 741:3\u201338","journal-title":"Ann N Y Acad Sci"},{"key":"10_CR3","first-page":"175","volume":"22","author":"P Lissoni","year":"2001","unstructured":"Lissoni P, Cangemi P, Pirato D et al (2001) A review on cancer-psychospiritual status interactions. Neuroendocrinol Lett 22:175\u2013180","journal-title":"Neuroendocrinol Lett"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-079X.1993.tb00478.x","volume":"14","author":"JGM Maestroni","year":"1993","unstructured":"Maestroni JGM (1993) The immunoneuroendocrine role of melatonin. J Pineal Res 14:1\u201310","journal-title":"J Pineal Res"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grimm","year":"1982","unstructured":"Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon. J Exp Med 155:1823\u20131841","journal-title":"J Exp Med"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/bjc.1995.130","volume":"71","author":"R Banks","year":"1995","unstructured":"Banks R, Patel PM, Selby PJ (1995) Interleukin-12: a new clinical player in cytokine therapy. Br J Cancer 71:655\u2013659","journal-title":"Br J Cancer"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.4049\/jimmunol.129.6.2463","volume":"129","author":"S Chouaib","year":"1982","unstructured":"Chouaib S, Fradelizi D (1982) The mechanism of inhibition of human IL-2 production. J Immunol 129:2463\u20132467","journal-title":"J Immunol"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01648882","volume":"68","author":"J Atzpodien","year":"1990","unstructured":"Atzpodien J, Kirchner H (1990) Cancer, cytokines and cytotoxic cells. Klin Wochenschr 68:1\u201311","journal-title":"Klin Wochenschr"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.1992.10.2.180","volume":"10","author":"SA Rosenberg","year":"1992","unstructured":"Rosenberg SA (1992) The immunotherapy and gene therapy of cancer. J Clin Oncol 10:180\u2013199","journal-title":"J Clin Oncol"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00002371-199705000-00001","volume":"20","author":"S Woijtowicz-Praga","year":"1997","unstructured":"Woijtowicz-Praga S (1997) Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J Immunother 20:165\u2013177","journal-title":"J Immunother"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295\u2013307","journal-title":"Nat Rev Immunol"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Battelli","year":"2007","unstructured":"Battelli E, Oukka M, Kuchroo VK (2007) TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345\u2013350","journal-title":"Nat Immunol"},{"key":"10_CR13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4049\/jimmunol.141.2.690","volume":"141","author":"A Kasid","year":"1988","unstructured":"Kasid A, Bell GI, Director EP (1988) Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors: autocrine inhibition of cellular proliferation and differentiation to immune killer cells. J Immunol 141:690\u2013695","journal-title":"J Immunol"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","volume":"11","author":"KW Moore","year":"1993","unstructured":"Moore KW, O\u2019Garra A, de Waal-Malefyt R et al (1993) Interleukin-10. Annu Rev Immunol 11:165\u2013172","journal-title":"Annu Rev Immunol"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V74.1.1.1","volume":"74","author":"T Kishimoto","year":"1989","unstructured":"Kishimoto T (1989) The biology of interleukin-6. Blood 74:1\u201310","journal-title":"Blood"},{"key":"10_CR16","first-page":"2471","volume":"556","author":"KL Kunutso","year":"2007","unstructured":"Kunutso KL, Disis ML, Salazar LG (2007) CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 556:2471\u20132485","journal-title":"Cancer Immunol Immunother"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1200\/JCO.2005.03.6830","volume":"24","author":"GC Cesana","year":"2006","unstructured":"Cesana GC, De Raffaele G, Cohen S et al (2006) Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J Clin Oncol 24:1169\u20131177","journal-title":"J Clin Oncol"},{"key":"10_CR18","first-page":"1621","volume":"49","author":"KA Foon","year":"1989","unstructured":"Foon KA (1989) Biological response modifiers: the new immunotherapy. Cancer Res 49:1621\u20131627","journal-title":"Cancer Res"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/nm1096-1096","volume":"2","author":"SI Gabrilovich","year":"1996","unstructured":"Gabrilovich SI, Chen HL, Girgis KR et al (1996) Production of vascular endothelial growth factor by human tumor inhibits the functional maturation of dendritic cells. Nat Med 2:1096\u20131103","journal-title":"Nat Med"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0192-0561(83)90020-6","volume":"5","author":"NP Plotnikoff","year":"1983","unstructured":"Plotnikoff NP, Miller GC (1983) Enkephalins as immunomodulators. Int J Immunopharmacol 5:437\u2013442","journal-title":"Int J Immunopharmacol"},{"key":"10_CR21","first-page":"14","volume":"25","author":"F Grotenhermen","year":"2004","unstructured":"Grotenhermen F (2004) Pharmacology of cannabinoids. Neuroendocrinol Lett 25:14\u201322","journal-title":"Neuroendocrinol Lett"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/07357908709170112","volume":"5","author":"W Regelson","year":"1987","unstructured":"Regelson W, Pierpaoli W (1987) Melatonin: a rediscovered antitumor hormone? Cancer Invest 5:379\u2013385","journal-title":"Cancer Invest"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-079X.1993.tb00481.x","volume":"14","author":"SF Sze","year":"1993","unstructured":"Sze SF, Ng TB, Liu WK (1993) Antiproliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 14:27\u201333","journal-title":"J Pineal Res"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/1097-0142(197001)25:1<135::AID-CNCR2820250120>3.0.CO;2-9","volume":"25","author":"A Riesco","year":"1970","unstructured":"Riesco A (1970) Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 25:135\u2013140","journal-title":"Cancer"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jnci\/61.1.5","volume":"61","author":"S Broder","year":"1978","unstructured":"Broder S, Muul L, Waidmann TA (1978) Suppressor cells in neoplastic disease. J Natl Cancer Inst 61:5\u201311","journal-title":"J Natl Cancer Inst"},{"key":"10_CR26","first-page":"422","volume":"6","author":"P Sacerdote","year":"1999","unstructured":"Sacerdote P, Panerai A (1999) Role of opioids in the modulation of TH1\/TH2 responses. Neuroimmunomodulation 6:422\u2013423","journal-title":"Neuroimmunomodulation"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ni1184","volume":"6","author":"RH Schwartz","year":"2005","unstructured":"Schwartz RH (2005) Natural regulatory T cells and self-tolerance. Nat Immunol 6:326\u2013330","journal-title":"Nat Immunol"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<241::AID-IJC16>3.0.CO;2-L","volume":"70","author":"MC Mormont","year":"1997","unstructured":"Mormont MC, Levi F (1997) Circadian system alterations during cancer processes: a review. Int J Cancer 70:241\u2013247","journal-title":"Int J Cancer"},{"key":"10_CR29","first-page":"4466","volume":"46","author":"R Wittington","year":"1993","unstructured":"Wittington R, Fauldsm D (1993) Interleukin-2. Drugs 46:4466\u20134483","journal-title":"Drugs"},{"key":"10_CR30","first-page":"1377","volume":"28","author":"P Lissoni","year":"2008","unstructured":"Lissoni P, Brivio F, Fumagalli L et al (2008) Neuroimmunomodulation in medical Oncology: application of psychoneuroimmunology with subcutaneous low- dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors. Anticancer Res 28:1377\u20131382","journal-title":"Anticancer Res"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/01.cji.0000186244.85058.1b","volume":"29","author":"F Recchia","year":"2006","unstructured":"Recchia F, Saggio G, Nuzzo A et al (2006) Multicentric phase 2 study of interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced non-small cell lung cancer. J Immunother 29:87\u201394","journal-title":"J Immunother"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s005200100281","volume":"10","author":"P Lissoni","year":"2000","unstructured":"Lissoni P (2000) Is there a role for melatonin in supportive care? Support Care Cancer 10:110\u2013116","journal-title":"Support Care Cancer"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-079X.1995.tb00177.x","volume":"19","author":"A Conti","year":"1995","unstructured":"Conti A, Maestroni GJM (1995) The clinical neuroimmunotherapeutic role of melatonin in Oncology. J Pineal Res 19:103\u2013110","journal-title":"J Pineal Res"},{"key":"10_CR34","first-page":"255","volume":"23","author":"P Lissoni","year":"2002","unstructured":"Lissoni P, Malugani F, Bordin V et al (2002) A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone. Neuro Endocrinol Lett 23:255\u2013258","journal-title":"Neuro Endocrinol Lett"},{"key":"10_CR35","first-page":"63","volume":"9","author":"P Lissoni","year":"1995","unstructured":"Lissoni P, Pittalis S, Rovelli F et al (1995) Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer. J Biol Regul Homeost Agents 9:63\u201366","journal-title":"J Biol Regul Homeost Agents"}],"container-title":["Methods in Molecular Biology","Psychoneuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-071-7_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T03:37:35Z","timestamp":1714621055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-071-7_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781627030700","9781627030717"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-071-7_10","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-62703-071-7","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"24 July 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}